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Abstract. The uptake of benzanthrone by rat skin showed saturation kinetics and was 
dependent upon the weight of skin and time, temperature and pH of the incubation medium. 
Heating of segments above 50°C caused significant lowering of the uptake. The uptake was 
irreversibly inhibited by HgCl2 and not by sodium arsenate, KCN, NaF, p-chloromercuriben 
zoate, N-ethyl-maleimide, cycloheximide, iodoacetic acid and 2,4-dinitrophenol suggesting 
that the uptake was not energy-dependent. Lipid micelles of the skin accounted for a part of 
the binding. Most of the benzanthrone taken up by the skin was effluxed through serum 
proteins. 
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Introduction 
 
Benzanthrone [7H-benz(de)anthracen-7-one], an anthraquinone derivative, is a 
dye intermediate commonly used for the synthesis of a number of vat and disperse 
dyes. Workers exposed to benzanthrone during its manufacture, pulverization 
and storage develop itching, burning sensation, erythema and pigmentation of the 
exposed as well as covered parts of the skin (Singh et al., 1967; Trivedi and Niyogi, 
1968; Singh and Zaidi, 1969; Singh, 1970). In acute stages, the skin becomes 
tender, rough and peals off easily. Singh et al. (1967) showed that prolonged 
exposure to benzanthrone in experimental animals stimulates cell growth of all the 
skin layers together with increased vascularity and fibrosis. These histopatho- 
logical reports indicate that the skin is equipped with a mechanism for the uptake 
of benzanthrone. In the present investigation, an attempt has been made to study 
the in vitro kinetics of benzanthrone uptake by skin and its transport into the 
serum. 
 
Materials and methods 
 
Chemicals 
 
Benzanthrone, obtained from Indian Dyestuff Industries, Kalyan, was purified on a 
neutral alumina column using 1,2-dichloroethane as an eluant. The pooled active 
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fractions were concentrated in a Buchi Rotavapor and finally dried in a vacuum 
oven. It gave one spot (Rf value, 0.58) by thin layer chromatography on silica gel- 
G plates using toluene as solvent system (Swicki et al., 1966). The purity of 
benzanthrone was further assessed according to the Indian Standard specifications 
(IS: 5044-1969), infra-red (IR), nuclear magnetic resonance (NMR) and Mass 
spectroscopy. Iodoacetic acid and N-ethylamaleimide were products of Sigma 
Chemical Co., St. Louis, Missouri, USA. p-Chloromercuribenzoate and glutathione 
were procured from V.P. Chest Institute, New Delhi. 2,4-Dinitrophenol and 2- 
mercaptoethanol were the respective products of B.D.H., Poole, England and E. 
Merck, Dermstadt, Germany. All other chemicals used were of the Analytical 
Reagent grade. 
 
Preparation of skin segments 
 
Male albino rats, weighing approximately 200 g, were drawn from Indian Toxico- 
logy Research Centre's stock colony. The dorsal surface of the skin was shaved 
with an Oster electric clipper (model Α5-00) and the animals sacrified by decapita- 
tion. Skin pieces from the shaved area were cut and soaked in chilled 150 mM KCl 
solution as described in the procedure of Sahib and Krishna Murti (1969).
 
Uptake studies 
 
To each 25 ml Erlenmeyer flasks containing 0.3-0.4g portions of skin segments and 
5.0 ml of Krebs Ringer bicarbonate (KRB) buffer, pH 7.4, 200 µg of benzanthrone 
(from 1 mg/ml ethanolic stock) was added. The blanks contained equal volume of 
ethanol. The flasks covered with aluminium foils were shaken in a metabolic 
shaker (120 strokes/min) for the required period. The effects of increasing weight 
of skin segments (0.1-0.5 g), varying concentrations of benzanthrone (50-500 µg) 
and time (10-180 min); temperature (25-70°C); inhibitors, namely, sodium arsenate, 
KCN, NaF, HgCl2, p-chloromercuribenzoate, N-ethylmaleimide, cycloheximide, 
iodoacetic acid and 2,4-dinitrophenol (at 0.01, 0.1 and 1.0 mM levels); reducing 
agents, namely, ascorbic acid, cysteine, sodium dithionite and sodium metabi- 
sulphite all at 1.0 mM concentration and pH 5.0-10.0 of the incubation medium, on 
the uptake of benzanthrone were studied. After incubation, the skin segments 
were washed, homogenized and used for the determination of benzanthrone. 
Alternatively, the washings were mixed with the supernatant and benzanthrone in 
the supernatant was extracted with 1,2-dichloroethane and estimated. The 
reliability of the extraction procedure was confirmed by recovery experiments in 
which known amounts of benzanthrone were added to the KRB-buffer and 
extracted with 1,2-dichloroethane in exactly the same manner as that of 
experimental animals. The recovery was between 98-100%.
 
Efflux studies 
 
Skin segments preincubated with 200 µg benzanthrone were washed twice with 
chilled KRB-buffer, pH 7.4 and transfered to flasks containing 5.0 ml of rat serum 
and shaken for 2 h. The skin segments were then removed and homogenized in 1,2- 
dichloroethane for the estimation of the remaining bound benzanthrone. Its 
transport into serum was calculated. The effect of serum dilutions (0.0, 2.5, 5.0, 
7.5 and 10.0 fold) and contact period (15-180 min) on the transport of benzanthrone 
was studied. 
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Preparation of homogenate 
 
Skin segments were thrown into liquid air, the frozen pellets thawed at room 
temperature and the operation repeated to get a pulpy mass that could be 
homogenized in a power-driven Potter-Elvehjem homogenizer with teflon pestle 
The homogenate was centrifuged at 2000 g for 15 min in a Remi T8 centrifuge. The 
homogenate was prepared in 1,2-dichloroethane to extract the bound benzanthrone 
from the skin segments completely.
 
Preparation of lipid micelles 
 
Lipids were extracted by homogenizing the skin segments with a chloroform-
methanol (2:1) mixture according to the procedure of Folch et al. (1957). The
lipids thus extracted were dispersed in 50 mM phosphate buffer pH 7.5, and
exposed to ultrasonic waves in a Vibronics Ultrasonic Processor (model VPL-P2)
for 10 min at 20 KHz and 150 mA current. After sonic disruption samples were
centrifuged at 5°C at 1,00,000 g for 60 min in an ultracentrifuge (MSE superspeed
75). The supernatant was used as the source of lipid micelles (Kapoor et al., 1972).
 
Binding of benzanthrone to lipid micelles 
 
Skin lipid micelles (1-10 mg) were allowed to interact with 50 µg of benzanthrone in 
50 mM phosphate buffer pH 7.5 for 1 h at 37°C. The unbound benzanthrone was 
recovered by centrifugation at 2000 g, in a Remi T8 centrifuge for 15 min extracted 
with 1,2-dichloroethane and estimated against suitable blanks.
 
Estimation of benzanthrone 
 
Benzanthrone was estimated by measuring the absorbance at 385 nm in an 
Unichem SP-500 spectrophotometer. The molar extinction coefficient (ε) of 
benzanthrone was 1.175×104 litre mol–1 cm–1 at 385 nm in 1,2-dichloroethane.
 
Results 
 
Uptake studies 
 
Effect of varying concentrations of benzanthrone: The rate of uptake as affected 
by concentration of benzanthrone in the medium is shown in figure 1. Increase in 
the concentration of benzanthrone upto 300 µg gives a linear relationship on the 
uptake per g of skin. Further increase in concentration does not enhance the 
uptake. 
 
Effect of skin weight: The uptake of benzanthrone by skin from the medium 
increases linearly on increasing the weight of the skin as illustrated in figure 2.
 
Effect of incubation time: Figure 3 shows the effect of time of incubation of skin 
segments in the medium containing benzanthrone. Maximum uptake was 
observed at 70 min. Further increase in incubation time showed no effect on the 
total uptake of benzanthrone. 
 
Effect of incubation temperature: The uptake (after 70 min of incubation) is 
initially temperature-dependent. maximum uptake is observed between 40-45°C, 
after which further increase in temperature decreases the uptake of benzanthrone 
(figure 4). 
382  Joshi et al. 
 
 
 
 
 
Figure 1.  Concentration dependence in relation to benzanthrone uptake. 
 
 
 
 
 
 
 
 
Figure.2  Effect of skin weight on the uptake of benzanthrone 
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Figure 3.  Uptake of benzanthrone in response to exposure time. 
 
 
 
 
Figure 4.  Effect of temperature on the uptake of benzanthrone. 
 
 
 
Effect of pH: The uptake of benzanthrone is increased as the pH of the 
incubation medium is increased from acidic to neutral. The optimum pH range is 
7.2-7.6. Further increase towards the alkaline region leads to a slow decrease in 
the uptake (figure 5). 
 
Effect of inhibitors: Sodium fluoride, iodoacetate, sodium arsenate, KCN, 
dinitrophenol and cycloheximide do not inhibit the uptake of benzanthrone at 
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Figure 5.  Influence of pH on the uptake of benzanthrone. 
 
 
0.01, 0.1 and 1.0 mM levels. HgCl2 has no effect at 0.01 and 0.1 mM. An inhibition 
of 43% in the uptake was observed at the highest concentration tested (1.0 mM) 
(table 1). The inhibition is not reversed by adding reduced glutathione and 2- 
mercaptoethanol to a final concentration of 1.0 mM.
 
 
 
Table 1.  Effect of inhibitors on the uptake of benzanthrone by rat skin. 
 
 
 
 
Effect of reducing agents: Ascorbic acid, cysteine, sodium dithionite and sodium 
metabisulphite have no effect on the uptake at the concentration tested (1.0 mM) 
(table 2). 
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Table 2.  Effect of reducing agents on the uptake of benzanthrone.
 
 
 
Transport studies 
 
Effect of serum concentration: Undiluted serum can transport out 84% of the 
skin-bound benzanthrone (in 120 min of incubation). With 5 and 10 fold dilution, 
40 and 13.5% benzanthrone is realised respectively indicating thereby that higher 
the dilution of serum lesser is its transport (table 3).
 
 
 
Table 3.  Relationship between benzanthrone transport and serum concentration. 
 
 
 
 
Effect of contact time on transport: The transport of benzanthrone into serum 
gradually increases with contact time. Maximum transport is encountered at 120 
min after which further increase in contact time has no influence on the total 
transport (figure 6). 
 
Binding study with isolated lipid micelles: As illustrated in table 4, binding of 
benzanthrone is linearly dependent on the amount of skin lipid micelles up to 10.0 
mg levels as tested in the present study.
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Figure 6.  Relationship between benzanthrone transport and contact time. 
 
 
 
Table 4.  Binding of benzanthrone to rat skin lipid micelles. 
 
 
 
 
Discussion 
 
The present study shows that rat skin could pick up benzanthrone from the 
medium and the skin bound benzanthrone could then be transported through 
serum. 
 
The uptake is temperature-dependent initially and increases exponentially with
rising temperature. This may be largely due to changes in the membrane diffusion 
constant (Blank et al., 1967) causing a decrease in the activation energies for 
diffusion across the stratum corneum (Scheuplein and Blank, 1971). The binding 
is sensitive to temperature above 50°C as the uptake is significantly decreased. 
Collagen, the major structural protein of skin, is known to undergo thermal 
denaturation at 52-53°C (Gross 1964). This may suggest that collagen is possibly 
one of the factors involved in the binding. Separate experiments with reconsti- 
tuted collagen fibrils and the effect of temperature are in agreement with this 
finding (Joshi et al., personal communication). Within a pH range of 5.0-10.0, 
maximum uptake occurs around pH 7.0-7.6. This behaviour is somewhat different 
from that of albumin, the binding property of which is limited to a narrow pH range 
(Hargreaves, 1968). 
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The uptake of benzanthrone is decreased by HgCl2 at 1.0 mM concentration. 
The inhibition is not likely to be due to the involvement of –SH groups because 
-SH binding agents such as p-chloromercuribenzoate and N-ethylmaleimide had 
no effect on the uptake; glutathione and 2-mercaptoethanol when added to the 
final concentration of 1.0 mM were without effect on the uptake. The inhibition 
by HgCl2 may be either due to the irreversible binding at the same site on the skin at 
which the benzanthrone binds, or due to its interaction with some other site on the 
skin not directly involved in the binding of benzanthrone which may result in a 
conformational change due to which the binding ability is decreased. The 
uncouples and inhibitors of oxidative phosphorylation showed no change on the 
benzanthrone uptake kinetics indicating it was not an energy dependent process. 
The absence of metabolic processes in the dead keratinizing layers precludes any 
role of active transport processes (Malkinson and Gehlmann, 1977) and molecules 
may diffuse across the stratum corneum by purely passive means (Treager,1966). 
 
No work on the metabolism of benzanthrone by skin has been reported this far.
However, this possiblity can not be ruled out under in vivo conditions. In order to 
confirm whether metabolism of benzanthrone takes place under our experimental 
condition and whether such metabolites might also be included in the estimation 
procedure, we performed a separate experiment with a view to identify the 
metabolites formed, if any by chromatography. Results of this study indicated the 
presence of only one spot corresponding to benzanthrone confirming that no 
metabolism occurs in skin segments. 
 
Serum proteins appear to have an affinity for benzanthrone as the skin-bound 
benzanthrone was transported into serum. The release of benzanthrone increased 
with increasing serum protein concentration. Acton (1968) showed that the 
fraction of a bound chemical increase with increasing protein concentration. A 
likely competition for benzanthrone between binding sites of the skin and serum 
proteins may exist. When all the binding sites of serum proteins are saturated 
there is no more efflux. A separate study (Joshi et al., personal communication) 
in which the protein bound benzanthrone was fractionated on Sephadex G-200 
column, revealed that benzanthrone has more affinity for albumins than the 
globulin fractions. 
 
Part of the uptake of benzanthrone by the skin could also be attributed to lipids 
present in the skin, as is evident from the binding of benzanthroneitoskin lipids 
micelles in vitro. 
 
On the basis of the above preliminary investigation, it may be assumed that 
benzanthrone due to its lipophilic nature is readily absorbed through the skin 
preferably crossing the lipoidal barrier of the epidermis and gets bound to certain 
specific sites in the skin. The skin-bound benzanthrone is subsequently released 
into circulation. 
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